SciELO - Scientific Electronic Library Online

 
vol.59 issue1Barriers for implementation of cosmetovigilance in Peru: Structural Equation modeling using partial least squarePharmacology of natural Products: an recent approach on Calotropis gigantea and Calotropis procera author indexsubject indexarticles search
Home Pagealphabetic serial listing  

Services on Demand

Journal

Article

Indicators

Related links

  • On index processCited by Google
  • Have no similar articlesSimilars in SciELO
  • On index processSimilars in Google

Share


Ars Pharmaceutica (Internet)

On-line version ISSN 2340-9894

Abstract

ALVAREZ BRENES, Rebeca; ZUNIGA VILLALOBOS, Keren; PACHECO MOLINA, Jorge Andrés  and  MORA ROMAN, Juan José. Heparin and enoxaparin dossiers review: non-compliance of the Costa Rican regulation for the sanitary registration of pharmaceutical biosimilars. Ars Pharm [online]. 2018, vol.59, n.1, pp.27-35. ISSN 2340-9894.  http://dx.doi.org/10.4321/s2340-98942018000100003.

Objective:

To determine the essential aspects of the Costa Rican regulation concerning the sanitary registration of biosimilars and to compare them with the information provided in the dossiers of laboratories manufacturing heparin and enoxaparin.

Methodology:

The regulation for the Registration and Control of Biological Drugs: RTCR 440: 2010 was reviewed. Subsequently, the dossiers sent by the manufacturers were requested, and their information was compared with the data requested by the previous regulation. Finally, the importance of this information was evaluated.

Results:

The national regulations require chemical, pharmaceutical and biological information on the finished pharmaceutical product, results on safety and efficacy, administrative data and legal documentation. For biosimilars, the biosimilitude exercise and a pharmacovigilance plan must be presented. This information is not available in its entirety in the reviewed dossiers.

Conclusions:

The products reviewed do not meet the requirements of the Costa Rican regulations regarding the biosimilitude exercise. Therefore, they were not submitted for their drugs' applications before the Ministry of Health of Costa Rica.

Keywords : Biosimilar pharmaceuticals; heparin; enoxaparin.

        · abstract in Spanish     · text in Spanish     · Spanish ( pdf )